PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Collapsing glomerulopathy in systemic lupus erythematosus.

Abstract Collapsing glomerulopathy (CG) is a rare disease that can be associated with multiple other disorders. It usually leads to poor prognosis with a high percentage of patients progressing to end-stage renal disease. In this article, we illustrate a clinical case of CG associated with systemic lupus erythematosus that had a prompt response to mycophenolate and prednisone. The condition started after sudden cessation of the already established mycophenolate treatment regimen. The patient then presented with acute kidney injury due to kidney biopsy-proven CG. In that circumstance, we hypothesised that mycophenolate may play a role in prevention and development of CG.
PMID
Related Publications

Collapsing glomerulopathy associated with proliferative lupus nephritis: reversible acute kidney injury.

A case of minimal change disease complicated by acute kidney injury in systemic lupus erythematosus.

Late recurrence of lupus nephritis in a renal transplant recipient: response to mycophenolate mofetil.

Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.

Hyperacute renal failure as the initial presentation of systemic lupus erythematosus.

Authors

Mayor MeshTerms

Kidney Glomerulus

Keywords
Journal Title bmj case reports
Publication Year Start




PMID- 28242801
OWN - NLM
STAT- MEDLINE
DA  - 20170228
DCOM- 20170310
LR  - 20170310
IS  - 1757-790X (Electronic)
IS  - 1757-790X (Linking)
VI  - 2017
DP  - 2017 Feb 27
TI  - Collapsing glomerulopathy in systemic lupus erythematosus.
LID - bcr2016217840 [pii]
LID - 10.1136/bcr-2016-217840 [doi]
AB  - Collapsing glomerulopathy (CG) is a rare disease that can be associated with
      multiple other disorders. It usually leads to poor prognosis with a high
      percentage of patients progressing to end-stage renal disease. In this article,
      we illustrate a clinical case of CG associated with systemic lupus erythematosus 
      that had a prompt response to mycophenolate and prednisone. The condition started
      after sudden cessation of the already established mycophenolate treatment
      regimen. The patient then presented with acute kidney injury due to kidney
      biopsy-proven CG. In that circumstance, we hypothesised that mycophenolate may
      play a role in prevention and development of CG.
CI  - 2017 BMJ Publishing Group Ltd.
FAU - Abadeer, Kerolos
AU  - Abadeer K
AD  - Department of Nephrology and Hypertension, Mayo Clinic Florida, Jacksonville,
      Florida, USA.
FAU - Alsaad, Ali A
AU  - Alsaad AA
AUID- ORCID: http://orcid.org/0000-0001-9143-5269
AD  - Department of Internal Medicine, Mayo Clinic Florida, Jacksonville, Florida, USA.
FAU - Geiger, Xochiquetzal J
AU  - Geiger XJ
AD  - Department of Pathology and Laboratory Medicine, Mayo Clinic Florida,
      Jacksonville, Florida, USA.
FAU - Porter, Ivan E
AU  - Porter IE
AD  - Department of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida,
      USA.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20170227
PL  - England
TA  - BMJ Case Rep
JT  - BMJ case reports
JID - 101526291
RN  - 0 (Immunosuppressive Agents)
RN  - HU9DX48N0T (Mycophenolic Acid)
SB  - IM
MH  - Acute Kidney Injury/etiology
MH  - Adult
MH  - Female
MH  - Humans
MH  - Immunosuppressive Agents/*therapeutic use
MH  - *Kidney Glomerulus
MH  - Lupus Erythematosus, Systemic/*complications/drug therapy
MH  - Lupus Nephritis/*drug therapy/etiology/pathology
MH  - Medication Adherence
MH  - Mycophenolic Acid/*therapeutic use
EDAT- 2017/03/01 06:00
MHDA- 2017/03/11 06:00
CRDT- 2017/03/01 06:00
AID - bcr-2016-217840 [pii]
AID - 10.1136/bcr-2016-217840 [doi]
PST - epublish
SO  - BMJ Case Rep. 2017 Feb 27;2017. pii: bcr2016217840. doi: 10.1136/bcr-2016-217840.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>